Press release
Circular RNA (CircRNA) Platforms Market to Reach USD 999 Million by 2035 Amid Rising RNA Therapeutics Demand
Circular RNA (CircRNA) Platforms Market to Reach USD 999 Million by 2035 Amid Rising RNA Therapeutics Demand
As innovation accelerates, companies across the circular RNA technology solutions market are investing in next-generation circRNA platforms that outperform traditional mRNA therapies in stability, durability, and efficiency.
To mark Black Friday, this research report is now available at a special 15% reduced rate, ensuring premium insights are more accessible than ever.
Buy Now: https://marketgenics.co/buy/circular-rna-circrna-platforms-market-19161
Rising Applications Fuel Market Growth
The Circular RNA (CircRNA) Platforms Market is gaining traction due to its transformative potential across various disease areas. circRNA molecules exhibit exceptional molecular stability, resistance to exonuclease degradation, and prolonged protein expression-features that make them ideal for next-generation therapeutics.
Key applications include:
Oncology and cancer therapeutics
Neurological and metabolic disorders
Rare genetic diseases
Infectious disease vaccines
Autoimmune and inflammatory conditions
The growing recognition of circRNA's therapeutic advantages is accelerating adoption across the global circular RNA technology solutions market, with advanced platforms enabling high-quality synthesis, design optimization, target validation, and delivery.
Therapeutic Development Dominates the Market
Therapeutic development accounts for 61% of the global market share in 2025. Biotechnology companies and academic institutions are leveraging circRNA to build highly targeted, stable, and scalable therapies.
Recent scientific advancements underscore this momentum:
Circio's circVec-AAV vectors (2025): Demonstrated up to 40-fold higher protein expression in vivo, reducing viral dosage requirements and making gene therapies safer and more cost-effective.
RiboX Therapeutics (Phase I/IIa): Successfully evaluated RXRG001, a circRNA therapy for radiation-induced xerostomia, demonstrating long-term activity and therapeutic stability.
Such developments reinforce the strong pipeline of candidates emerging from the broader circular RNA technology solutions market, with companies innovating across sequencing, synthesis, delivery, and computational design.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Circular RNA (CircRNA) Platforms Market Research Report: https://marketgenics.co/reports/circular-rna-circrna-platforms-market-19161
Demand Surge Driven by Precision Medicine & Drug Discovery
The demand for circRNA platforms is rapidly increasing as precision medicine programs expand globally. Pharmaceuticals and biotech organizations are adopting circRNA systems to support:
High-throughput drug discovery
Personalized RNA therapeutics
Predictive molecular profiling
Advanced gene-modulating therapies
The Circular RNA (CircRNA) Platforms Market is also benefiting from growing interest in AI-enhanced RNA design. Platforms like CircNova's AI-powered NovaEngine streamline circRNA prediction, structural optimization, and synthesis, significantly accelerating development timelines.
Key Market Drivers
Growing Therapeutic Potential in Oncology
circRNA is becoming a cornerstone of next-generation cancer therapies due to its enhanced stability and long-lasting protein expression.
Ginkgo Bioworks & Esperovax Inc. collaborated to develop circRNA therapeutics for colorectal cancer.
Circio's circAde builds on ONCOS-102 results, demonstrating strong anti-tumor immune responses.
Such innovations amplify investments across the circular RNA technology solutions market, delivering strong momentum for oncology-focused R&D.
Advancements in circRNA Delivery Technologies
Efficient delivery remains a critical component of circRNA therapeutic success.
Leading breakthroughs include:
Orna Therapeutics' panCAR platform: Achieved 84% T-cell uptake using LNP-based circRNA delivery, resulting in 95% reduction in B cells.
Lipid nanoparticles, polymeric carriers, and exosome-based systems continue to enhance targeted delivery and reduce immunogenicity.
AI-Driven Innovation
AI is revolutionizing circRNA design, enabling:
Predictive modeling
High-precision molecule synthesis
Structural optimization
Target-specific circRNA development
Integration of AI strengthens both the Circular RNA (CircRNA) Platforms Market and the large ecosystem of circular RNA technology solutions used for discovery, design, and therapeutic development.
To know more about the Circular RNA (CircRNA) Platforms Market - Download our Sample Report: https://marketgenics.co/download-report-sample/circular-rna-circrna-platforms-market-19161
Challenges Hindering Market Expansion
Despite strong growth, certain restraints are slowing commercialization:
High complexity of circRNA production
Lack of standardized purification protocols
High cost of large-scale manufacturing
Regulatory uncertainties in new RNA modalities
These challenges present opportunities for technology innovators to disrupt the circular RNA technology solutions market with scalable, standardized, and automated circRNA production platforms.
North America Leads the Market
North America holds ~45% market share in 2025 owing to:
Advanced healthcare infrastructure
Robust regulatory frameworks
Strong academic-industry partnerships
High biotechnology investment activity
Institutions like the University of Pennsylvania and Mass General Brigham are pioneering circRNA manufacturing, delivery innovation, and personalized RNA therapeutics.
Get a preview of our Circular RNA (CircRNA) Platforms Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/circular-rna-circrna-platforms-market-19161
Competitive Landscape
The Circular RNA (CircRNA) Platforms Market is moderately consolidated. Key players include:
GenScript Biotech
Oxford Nanopore Technologies
Illumina
Orna Therapeutics
Laronde
Arraystar
Creative Biogene
Circio
CloudSeq Biotech
These companies dominate the circular RNA technology solutions market, offering advanced sequencing, synthesis, bioinformatics, and delivery technologies tailored for circRNA applications.
Future Opportunities: A Market Poised for Transformation
The global Circular RNA (CircRNA) Platforms Market will create an additional USD 785.8 million in new opportunities by 2035. Emerging areas with high market potential include:
Tissue-specific circRNA therapeutics
Oncology and immunotherapy innovations
Vaccine development using thermostable circRNA nanoparticles
circRNA-based microRNA sponges and decoys
AI-enhanced circRNA functional mapping
Next-generation LNPs tailored specifically for circular RNA
Development of endogenous circRNA modulators and synthetic circRNA libraries is expected to significantly boost pipeline diversity.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Circular RNA (CircRNA) Platforms Market to Reach USD 999 Million by 2035 Amid Rising RNA Therapeutics Demand here
News-ID: 4280145 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
Automotive Tire Market Set to Reach USD 212 Billion by 2035, Driven by Rapid OEM …
The Automotive Tire Market is entering a transformative decade driven by rising vehicle production, the rapid adoption of electric mobility, and the rising demand for sustainable and smart tire technologies. Valued at USD 152.5 billion in 2025, the market is projected to reach USD 212.0 billion by 2035, expanding at a CAGR of 4.2%. The growth is strongly supported by advancements in materials, digitization of tire performance monitoring, and major…
Contract Cleaning Services Market to Surpass USD 641.5 Billion by 2035 | Demand …
The Contract Cleaning Services Market is witnessing significant transformation as businesses across the world increasingly prioritize hygiene, sustainability, and operational efficiency. Valued at USD 310.8 billion in 2025, the market is projected to more than double, reaching USD 641.5 billion by 2035, rising at a CAGR of 6.8%. This expansion is driven by rising outsourcing trends, high demand for specialized cleaning services, rapid technological integration, and heightened awareness of workplace…
Micro-Inverter Market Surges to USD 34.5 Billion by 2035 Driven by Distributed S …
The Micro-inverter Market is entering a transformative phase driven by growing residential solar adoption, rapid digitalization, and expanding integration of energy storage solutions. Valued at USD 4.7 billion in 2025, the market is projected to reach USD 34.5 billion by 2035, reflecting an impressive 19.8% CAGR. As the solar industry transitions toward smarter, more reliable, and efficiency-driven technologies, micro-inverters are increasingly becoming a cornerstone of distributed renewable systems. Parallel markets…
3D Printing Plastics Market Records 18.9% CAGR Growth; North America Leads with …
The 3D Printing Plastics Market is undergoing a transformative growth cycle fueled by rapid advancements in additive manufacturing, increasing adoption across key industries, and the rising need for sustainable and high-performance materials. Valued at USD 1.9 billion in 2025, the market is projected to surge to USD 12.6 billion by 2035, registering an impressive CAGR of 18.9%. This growth aligns with the broader expansion of the 3D Printing Materials Market,…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
